Current Challenges and New Opportunities in Follicular Lymphoma

STATEMENT OF NEED Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab...
Postgraduate Institute for Medicine and i3 Health

Challenges and Opportunities in Hodgkin Lymphoma

STATEMENT OF NEED Hodgkin lymphoma (HL) is a rare malignancy involving the lymph nodes and lymphatic system, with 8,500 new cases diagnosed and accounting for 1,050 deaths each year in the United States. In contrast with other cancers whose risk increases with age, the risk for HL increases in patients between 15 and 30 years of age, decreases during middle age, and is followed by another peak in adults older than 55. There are 2 main types of HL: classical HL, which accounts for 95% of cas...
i3 Health

Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies

STATEMENT OF NEED Although the clinical outcomes of patients with B-cell malignancies such as diffuse large B-cell lymphoma and B-cell acute lymphoblastic leukemia have improved during the past decade, many continue to develop relapsed or refractory disease, representing a significant cause of morbidity and mortality. CAR T-cell therapy has been shown to produce significant antitumor responses in these patients, for whom treatment options are limited. However, CAR T-cell therapy is associat...
i3 Health

Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia

STATEMENT OF NEED Waldenstrom macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by lymphoplasmacytic bone marrow infiltration and the presence of serum monoclonal IgM. With an estimated 1,500 new cases reported in the United States annually, the malignancy accounts for 2% of non-Hodgkin lymphomas. Unfortunately, WM is considered incurable with available therapies. Patients with low- and intermediate-risk disease have 5-year survival rates of 87% and 68%, respective...
i3 Health

Internal Medicine Comprehensive Review and Update 2019

This CME program from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital provides comprehensive instruction to ensure clinicians are current with the latest evidence and best practices for: • Cardiovascular Medicine • Pulmonary Medicine • Critical Care • Hematology and Oncology • Mind-Body Medicine • Infectious Diseases • Gastroenterology • Endocrinology • Rheumatology • Nephrology • Travel Medicine • Allergy and Immuno...
Harvard Medical School

New Insights into the Understanding of Thrombosis & Hemorrhage in Myeloproliferative Neoplasms: Improving Patient Outcomes

The myeloproliferative neoplasms (MPNs) are a group of hematologic malignancies that are associated with an extraordinary high incidence of thrombotic and hemorrhagic complications. In fact, these thrombotic events are the major cause of morbidity and mortality in patients with MPNs. Despite the importance of these events, our understanding of the pathobiology of thrombosis and hemorrhagic events in this group of disorders is understood only to limited extent. Thus, this meeting has been o...
Melton Medical Education, LLC

The Brigham Board Review in Hematology

Topics covered by The Brigham Board Review in Hematology include:  Hematopoietic Stem Cell Transplantation, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndromes, Hodgkin's Lymphoma, Bone Marrow Failure, Hemophagocytic Syndromes, Sickle Cell Disease, Thalassemia and many others. After completing The Brigham Board Review in Hematology, you will be able to: • Apply current/recommended Hematology guidelines in clinical practice • Perform differential diagnosis of comple...

The Brigham Board Review in Hematology and Oncology

Get ready for the ABIM exam in Hematology-Oncology by studying this Brigham Board Review in Hematology and Oncology. Topics covered by the Brigham Board Review in Hematology and Oncology include: Molecular Genetics of Cancer, Cancer Drug Development, Hematopoietic Stem Cell Transplantation, Acute Leukemias, Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin's Lymphoma, B Cell Malignancies, Mesothelioma, Thyroid Cancer and dozens of others. After completing the Brigham Board Review in Hemat...

2nd Annual Aspen Conference on Pediatric Cerebrovascular Disease and Stroke

Thought leaders in this emerging field will convene over the course of one week to share ideas, learn and create pathways to deliver cutting edge care to pediatric and young adult cerebrovascular and stroke patients. Major Topic Areas: • Endovascular Management Options for Acute Stroke • Hemorrhagic Stroke (Cerebral Aneurysms, AVMs, Moyamoya, Cardioembolic, and Vasospasm) • Sickle Cell Related Cerebrovascular Complications • Cerebral Arteriopathy and Acute Stroke Mimics • ...
Cincinnati Children's Hospital Medical Center

29th Annual Mayo Clinic Hematology/Oncology Reviews 2019

Mayo Clinic's 29th Annual Hematology/Oncology Reviews 2019 in Amelia Island, Florida is a comprehensive review of hematology/oncology that focuses on the application of new clinical and research advancements and developments over the preceding year. The most important clinical management questions in hematology/oncology will be addressed in highly interactive sessions. Attendees will leave with up-to-date, practical information which will have immediate clinical application. Attendees are enc...
Mayo Clinic

Intensive Review of Internal Medicine

The Acclaimed Clinical Update and Board Review With more than 120 interactive lectures, case discussions, and board preparation sessions, this CME program is the most comprehensive review of internal medicine offered by the clinical faculty of Harvard Medical School. One of the highest-rated Harvard Medical School CME courses, it sold out the last two years, so early registration is advised. It offers accelerated learning: ► For clinicians seeking a practical and comprehensive review ...
Harvard Medical School

Overcoming Analysis Paralysis: Laboratory and Diagnostic Test Interpretation - Honolulu

Test Your Skills ~ 1. What is the significance of an elevated mean corpuscular volume (MCV)? 2. What does an elevated blood urea nitrogen (BUN) level with a normal creatinine level indicate? 3. What is the diagnostic difference between ST depression and ST elevation? 4. How does pregnancy affect fibrinogen or platelet levels? This seminar will look at the answers to these and many other questions regarding laboratory and diagnostic tests. Participants will learn the significance of bo...

Crucial Conversations in Oncology Nursing: Management Considerations for the AML Patient

The landscape of AML treatment is evolving and newer targeted agents may improve outcomes for selected subgroups of patients. Oncology nursing professionals provide disease and treatment information, manage adverse effects, and offer emotional support. Knowledge of the key management issues for patients with AML is critical in fulfilling this role. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and po...
American Academy of CME

12th International Congress on Myeloproliferative Neoplasms

Since its inception 18 years ago, the International Congress on Myeloproliferative Neoplasms has provided a forum for the interaction of practicing hematologists, oncologists, translational scientists, and other healthcare professionals with experts from both the US and Europe in the myeloproliferative neoplasms, including chronic myeloid leukemia, the hyper-eosinophilic syndromes and mastocytosis. This year’s CME-accredited program will feature the latest information on the pathophysiology ...
Melton Medical Education, LLC

TKI Therapy in CML: Emerging Treatments, Ensuring Safety

This Virtual Practice summarizes advances in tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) in the context of disease- and patient-specific characteristics; reviews the most effective methods for monitoring early response and long-term therapeutic outcomes; assesses the milestones and mutational analyses to identify when a change in TKI therapy is needed; compares toxicity profiles of the currently available TKI agents; and examines how toxicity could interact with...
Albert Einstein College of Medicine and RedMedEd

Primary Care Internal Medicine

The Comprehensive 2019 Primary Care Update Updates, advances, and best practices to optimize patient care and clinical outcomes. Designed for busy clinicians, this comprehensive Harvard Medical School CME program ensures that you are current with the most important clinical changes and innovations impacting primary care and prepared to integrate them into your practice. In one immersive experience, participants learn advances and improved approaches to: • Cardiovascular disease • Di...
Harvard Medical School

Update in Hospital Medicine 2019

Comprehensive updates, advances, and best practices to optimize inpatient care This 3-day intensive Harvard Medical School CME program, which has sold out for the past 4 years, updates busy practitioners on current, best practices in hospital medicine. Among the highest-rated Harvard CME courses, the curriculum covers over 30 core topics, with an emphasis on practical management of common problems: • Heart failure • Atrial fibrillation • Acute coronary syndromes • Diabetes • EC...
Harvard Medical School

Board Vitals Hematology and Oncology Board Review Question Bank

The Hematology and Oncology Board Review Question Bank features over 800 Hematology and Oncology questions. The Hematology Oncology exam study guide features: • Over 800 review questions and answers • The leading digital question bank for Oncology Board Prep • Percent correct provided on most questions to compare against the national average • Timed mode available to simulate exam conditions • Access from any computer or smartphone! • Also available: CME Redemption
Board Vitals

The Evolution of Multiple Myeloma Patient Management: Managing Today, Preparing for Tomorrow

The clinical multiple myeloma arena has undergone significant advances in diagnosis and prognosis, minimal residual disease monitoring, and supportive care. This expansion brings renewed hope to patients, but it presents new challenges for the clinicians charged with their care. Some patients enjoy many years in clinical remission, whereas for others survival is no more than 2 or 3 years. This reflects the heterogeneity of myeloma and underscores the inappropriateness of a one-size-fits-all ma...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Challenges of Diagnosing and Caring for an Individual with Gaucher Disease

Although making a proper diagnosis can sometimes be a challenge even for common illnesses, in cases of patients who present with a rare disease such as Gaucher disease, properly diagnosing the disorder is especially challenging. Gaucher disease specialists often come across individuals who have lived with symptomatic Gaucher disease for years—into middle age or beyond—at which point treatment is much less effective. Although these individuals can gain some benefit from treatment, irreversi...

Clinical Updates in Chronic Myeloid Leukemia: New Understandings in Disease Diagnosis, Monitoring and Personalized Therapeutic Regimens Utilizing Tyrosine Kinase Inhibitors

Advance your understanding on how to better diagnose, treat, and monitor CML. Expert faculty from MD Anderson recently gave a series of lectures across the country on the latest research and treatment regimen recommendations in CML. Highlighting key takeaways from this meeting series, faculty review the role of ABL tyrosine kinase inhibitor (TKI) agents in advancing treatment and delivering up-to-date care as well as discuss safety and tolerability of various approved TKIs in CML. They examine...

Treating B-Cell Lymphomas: Novel Agents and the Evolving State of Practice

Over the last several decades, advances in non-Hodgkin lymphoma (NHL) management have improved survival; however, relapse and the emergence of treatment-resistant NHL following standard therapy remain ongoing treatment challenges. With conventional therapy for B-cell NHL, response rates are suboptimal and many patients relapse, highlighting the need for novel treatments that address the risk of disease progression. Recently, several novel therapies—including small-molecule inhibitors of the ...
Horizon CME, the Washington State Pharmacy Association (WSPA), and RedMedEd

The University of Chicago Digestive Diseases Review: University of Chicago Medicine & Biological Sciences Specialty Review (SA-CME)

Studying the University of Chicago Digestive Diseases Review will help you to better: • Keep up with the latest advancements regarding the biology and treatment of patients with digestive diseases • Apply new knowledge in GI, hematology, and nutrition with this review in gastroenterology • Integrate current guidelines into daily practice when preventing and managing digestive diseases

Board Vitals Family Medicine MOC Re-Certification Question Bank and Review

Board Vitals Family Medicine MOC Re-Certification Question Bank and Review contains over 1500 ABFM and AOBFP Family Medicine MOC targeted review questions. The Board Vitals FM qbank offers questions that are directly relevant to the exam: multiple choice questions (mostly focused around patient scenarios) with a single best answer. Board Vitals Family Medicine MOC Re-Certification Question Bank Features: • Take the exam in review mode or timed mode to simulate real FM exam conditions • ...
Board Vitals

Board Vitals USMLE Step 2 Board Review Questions and Practice Tests

Board Vitals USMLE Step 2 Board Review Questions and Practice Tests • Over 1000 USMLE Step 2 Board Review Questions • 100% Pass Guarantee! • Higher Pass Rate Than The National Average • Individualized Learning Based on Performance
Board Vitals

Board Vitals USMLE Step 3 Board Review Questions

Board Vitals USMLE Step 3 Board Review Questions: • 1200 USMLE Step 3 board review questions • Individualized learning • Ability to flag questions for further review • Question are structured by category • Timed and review modes available • Detailed explanations associated with each question
Board Vitals

Board Vitals Internal Medicine Board Review Question Bank and Study Program

The Board Vitals Internal Medicine Board Review Question Bank and Study Program covers topics from Allergy and Immunology to Pulmonary topics - all of the subjects covered on the Internal Medicine Board Exam.  The bank offers over 1200 questions targeted to the ABIM and ABOIM exams.  The Internal Medicine review is highly interactive, offers high yield questions, and offers related images in a manner similar to the board exams.
Board Vitals

Osler Pathology Online Review

After completing the Osler Pathology Online Review, you will be able to: • Use the evidence-based information and practice tools presented to better formulate differ- ential diagnoses for most clinical scenarios • Effectively apply current practice guidelines published by CAP, ASCP and other major medical and governmental agencies • Recognize common patterns of test results and recommend additional tests, as needed, to characterize the etiology and prognosis of individual patient cond...
Osler Institute

Guideline Update Series: American Society of Hematology Venous Thromboembolism Guideline Update

Need help staying current on recent changes in clinical practice guidelines? This session is for you! This 30-minute presentation provides a practical review of the American Soceity of Hematology 2018 guidelines for the treatement of venous thromboemboism treatment. Listen to a quick summary of what’s changed and how to apply these changes to patients in your practice.

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.